RAD-140 (Testolone) Before-and-After Results, Dosages, and More
Disclaimer: Selective androgen receptor modulators (SARMs) are not approved by the Food and Drug Administration (FDA) and may cause adverse effects in animals and humans. Dr. George Touliatos is available for consultation should readers have any questions or concerns.
RAD-140, or Testolone, is a nonsteroidal SARM that replicates the hypertrophic effects of anabolic steroids by binding to the androgen receptor (AR) [1].
RAD-140 is the first SARM to exhibit neuroprotective properties in preclinical research [2]. It achieves this by selectively stimulating the AR in neural tissue, activating the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathway.
RAD-140 surfaced in 2010 after being formulated by Radius Health, a U.S. biotechnology company. It is also known as:
- EP0062
- Vosilasarm
This guide aims to inform readers about:
- The physiological and pharmacological effects of RAD-140
- Evidence-based strategies to minimize potential adverse effects of RAD-140
- Reputable RAD-140 sources for research-supported procurement
RAD-140 was developed as a potentially effective and safer alternative to anabolic steroids for patients experiencing:
- Osteoporosis (reduced bone density) [3]
- Cachexia (loss of muscle mass) [4]
- Anemia (reduced red blood cell count)
However, the clinical safety of RAD-140 has not yet been conclusively established [5,6,7].
Dr. Thomas O’Connor has treated thousands of men who have used SARMs, and he notes that RAD-140 is not primarily used by bodybuilders.
Instead, Dr. O’Connor states that RAD-140 is commonly employed as a preparatory step before the use of anabolic steroids.
How Does RAD-140 Work?
RAD-140 has three main mechanisms of action:
- Target receptor binding and affinity
- Tissue selectivity
- Downstream cellular effects
Target Receptor Binding and Affinity
At the cellular level, RAD-140 acts directly on the AR, a ligand-dependent transcription factor.
RAD-140 possesses an exceptionally strong binding affinity for the AR. Its inhibition constant (Ki) is approximately 7 nM, making it more tightly binding than native testosterone (Ki ≈ 29 nM) and dihydrotestosterone (DHT) (Ki ≈ 10 nM).
Tissue Selectivity
Unlike traditional anabolic steroids, which uniformly activate ARs across all body tissues, RAD-140 displays tissue-selective agonist activity.
RAD-140 works as a full agonist in skeletal muscle and bone but acts as a weak partial agonist or antagonist in androgenic tissues like the prostate.
When RAD-140 binds, its unique nonsteroidal chemical structure forces the AR into a specific 3D shape. This shape selectively allows the recruitment of specific coactivator proteins (which turn gene transcription “on”) in muscle cells.
In contrast, in the prostate, this shape favors the recruitment of corepressor proteins (which keep gene transcription “off”).
Downstream Cellular Effects
Once inside the nucleus of target skeletal muscle and bone cells, the RAD-140-AR complex binds to specific DNA sequences known as androgen response elements (AREs). This initiates gene transcription:
- Protein Synthesis Upregulation: It triggers the transcription of structural proteins, significantly increasing muscle protein synthesis while simultaneously down-regulating pathways responsible for muscle protein breakdown.
- MAPK Signaling Pathways: In addition to classic genomic pathways, preclinical studies show RAD-140 activates neuroprotective and growth pathways via MAPK signaling and ERK phosphorylation [8].
RAD-140 Before-and-After Pictures

Disclaimer: Results from RAD-140 may vary based on individual genetics, nutrition, and user objectives.
This Reddit user stacked RAD-140 with LGD-4033. LGD-4033 is also known as:
- VK5211
- Ligandrol
- Anabolicum
The individual also administered MK-677, commonly known as Ibutamoren. Although some fitness enthusiasts commonly refer to MK-677 as a SARM due to its anabolic effects [9], it is technically a growth hormone secretagogue (GHS).
We observe that RAD-140, LGD-4033, and MK-677 stacks are used by certain weightlifters during bulking cycles.
The individual experienced substantial muscle growth, accompanied by a modest increase in visceral adiposity, as evidenced by more prominent abdominal hypertrophy.

Disclaimer: Results from RAD-140 may vary based on individual genetics, nutrition, and user objectives.
The user’s increase in abdominal circumference may be attributed to their use of MK-677, as growth hormone enhancers have been shown to increase insulin resistance and promote lipogenesis in scientific literature [10,11,12]. Lipogenesis is the metabolic process of synthesizing fatty acids and triglycerides (fats) from non-lipid substrates—including excess carbohydrates and proteins—to store energy.
This user’s results, in terms of muscle hypertrophy (size), can be considered moderate. However, the transformation is less dramatic than what is typically observed from a first anabolic-steroid cycle.
Based on visual assessment, it is estimated that this individual has gained approximately 5 kg (11.02 lb) of lean mass.
In animal studies, RAD-140 has demonstrated substantial increases in lean body mass [13]. However, in humans, the observed effects tend to be comparatively modest.
Clinical trials have evaluated the anabolic effects of testosterone enanthate in comparison to SARMs. In one study, SARMs added 1–1.5 kg (2.20–3.31 lb) of lean mass gain over 4–6 weeks, while testosterone enanthate caused an increase of 5–7 kg (11.02–15.43 lb) [1].
Jake Puskas, who holds a Master of Science (MSc) in Biology from Lakehead University, is a researcher specializing in the effects of RAD-140. Puskas states that it has the potential to be an effective treatment for individuals suffering from sarcopenia and osteoporosis.
However, owing to the limited number of clinical trials investigating RAD-140, Puskas proposes that short cycling protocols may be advantageous for certain study subjects.
This approach could facilitate a more comprehensive understanding of the SARM’s effects and potentially mitigate adverse outcomes.
12-Week Transformation

Disclaimer: Results from RAD-140 may vary based on individual genetics, nutrition, and user objectives.
This Reddit user’s cycle:
| Week | RAD-140 Dosage |
|---|---|
| 1–12 | 17 mg/day |
They experienced modest improvements in muscularity, accompanied by a slight increase in subcutaneous adipose tissue.
The individual gained approximately 2.3 kg (5.07 lb), partly due to adipose tissue accumulation, resulting from 12 weeks of a modest caloric surplus. Other users may not experience increased adipose tissue if they consume maintenance calories or less.
In comparison to the initial RAD-140 before-and-after transformation, this individual has not exhibited a significant increase in visceral fat. This suggests that the expansion in abdominal circumference in the other individual may be attributable to MK-677 rather than RAD-140.
8-Week Transformation

Disclaimer: Results from RAD-140 may vary based on individual genetics, nutrition, and user objectives.
The Reddit user took less than 10 mg of RAD-140 per day for most of his 8-week cycle. His results suggest that notable results can still occur at lower dosages.
This individual experienced substantial adipose tissue mass reduction despite maintaining a caloric surplus. Thus, other users may experience enhanced fat loss compared to this individual if they eat in a calorie deficit.
The individual reported that, despite gaining 4 kg (8.82 lb), RAD-140 was not considered worthwhile due to the occurrence of alopecia and the perception that the results were “insubstantial.”
The user’s experience suggests that administering low doses of RAD-140 may enhance its favorable risk-to-benefit profile, as evidenced by a 4 kg (8.82 lb) weight gain accompanied by a significant reduction in subcutaneous fat.
However, individuals predisposed to androgenetic alopecia may experience increased hair shedding when using RAD-140. This form of alopecia is typically temporary and unlikely to worsen unless the compound is misused.
Disclosure: We do not accept third-party advertising on Inside Bodybuilding. Our revenue is generated through doctor consultations and carefully selected pharmaceutical recommendations, which have consistently provided our patients with excellent results.
Best SARM Company in 2026
SwissChems
SwissChems is our recommended source for SARM capsules, guaranteeing a minimum purity of 99% across all its products.
SwissChems offers worldwide shipping, allowing non-U.S. researchers to access high-quality SARMs.
U.S. orders are delivered within 3–7 business days, while international orders typically arrive in 2–3 weeks.
10% coupon code: INSIDE10
Sports Technology Labs
Sports Technology Labs is a highly cost-effective liquid SARM source for U.S. researchers, offering purity levels exceeding 98%, as confirmed by third-party certificates of analysis (COAs).
Sports Technology Labs is one of the few SARM companies that accepts debit and credit cards, including Visa, Mastercard, and American Express, without additional fees at checkout.
Sports Technology Labs is only a viable source for U.S. researchers, as the company no longer provides international shipping.
15% coupon code: INSIDE15
Note: Sports Technology Labs’ products are regularly tested by MZ Biolabs, an independent laboratory with a U.S. Drug Enforcement Administration (DEA) Schedule III license.
RAD-140 Dosages

RAD-140 is not an FDA-approved pharmaceutical, so standardized dosage guidelines have not been established.
Nonetheless, we commonly observe male patients taking 10–20 mg per day for 6–12 weeks to improve body composition.
The majority of our patients report taking RAD-140 during bulking phases for muscle and strength gain. Other patients take it during cutting phases for fat loss and muscle retention.
Our patients who are novice SARM users often take lower doses, such as 10 mg per day, while more intermediate or advanced users commonly increase the dose to 20 mg per day.
Additionally, female users typically take lower doses than male users, often due to differences in body weight.
RAD-140 Cycle: What We Have Observed in Males
RAD-140 is generally available in the form of 10 mg capsules or as a 10 mg/mL solution. Individuals who dislike the taste of liquid SARMs may opt for capsules, while those on a budget may prefer liquid RAD-140, as it is often more affordable.
| Week | RAD-140 Dosage |
|---|---|
| 1–8 | 10 mg/day |
RAD-140 Cycle: What We Have Observed in Females
Our female patients typically administer a dosage of 5–10 mg per day over 8 weeks, allowing them to experience the benefits of RAD-140 while minimizing the risk of virilizing (masculinizing) effects.
| Week | RAD-140 Dosage |
|---|---|
| 1–8 | 7.5 mg/day |
If a woman’s goal is to build significant amounts of muscle and strength, she may be more likely to take a higher dose of 10 mg per day for maximum anabolism. In contrast, a woman whose objective is to retain muscle during a calorie deficit is more likely to take 5 mg per day.
How Does RAD-140 Compare with Anabolic Steroids?
Although anabolic steroids can lead to substantial gains in lean mass, they are also associated with adverse side effects affecting:
Thus, through the mechanism of tissue selectivity, RAD-140 was developed to mimic the anabolic effects of steroids—potentially offering similar benefits with fewer side effects [19].
However, in human and animal studies, RAD-140 has been shown to replicate the toxicity associated with Anavar (oxandrolone) and Primobolan (metenolone) [20,21,22].
A few of our bodybuilding patients who have used RAD-140 alongside anabolic steroids describe RAD-140 as “the SARM equivalent of testosterone.”
Consequently, we find that some weightlifters choose RAD-140 to increase anabolism, as it is perceived to have a safer toxicity profile than other SARMs such as S23 or YK-11 (Myostine).
It is important to note that people can respond differently to anabolic steroids and SARMs. For example, a man might take RAD-140 to increase his strength and notice no adverse effects from an 8-week cycle. In contrast, another man may take RAD-140 for 1 week and experience high blood pressure and hair loss.
Thus, a person’s genetics can often dictate how they respond to drugs, meaning there is no predictable or certain outcome from taking SARMs or anabolic steroids.
How Effective Is RAD-140 in Preclinical Research?
RAD-140 is widely considered one of the more potent SARMs, with it possessing superior anabolic effects to testosterone propionate in animal trials.
In a controlled experimental study, non-human primates exhibited a 10% increase in lean body mass following 28 days of RAD-140 administration [23].
RAD-140 can induce lipolysis (the process by which the body uses stored adipose tissue as its primary energy source) similar to anabolic steroids.
Additionally, RAD-140 users frequently report notable increases in muscular strength, attributable to its high affinity for binding to the AR.
Is RAD-140 Legally Approved for Research Use?
RAD-140 has not received approval for human use from the FDA. Consequently, it is an unapproved investigational compound that is legally permitted only for laboratory research.
RAD-140 is strictly prohibited for human consumption in the United States and most other countries worldwide.
The FDA has documented reports of adverse effects associated with RAD-140 and other SARMs, and it encourages individuals to report any adverse reactions through the MedWatch Online Voluntary Reporting Form.
RAD-140 is prohibited by the World Anti-Doping Agency (WADA) in sports. Consequently, its use is forbidden for professional athletes, along with other SARMs [24].
WADA states that RAD-140 and other SARMs can undermine the spirit of sports by leading to unfair advantages and compromising athletes’ health.
Several athletes have been suspended for using RAD-140 in competitive sports, including CrossFit athlete Ricky Garard.
Garard was disqualified in 2017 and subsequently received a four-year ban after securing third place in the 2017 Reebok CrossFit Games.
Garard claimed that he was misled into believing that RAD-140 was a legal supplement and maintained that its use did not create an unfair advantage, citing the prevalence of performance-enhancing drug (PED) use among his competitors.
Gil Roberts, an American sprinter and gold medalist at the 2016 Olympic Games, also tested positive for RAD-140 in 2023. Roberts stated that the test was conducted out of season and offered no excuses for the violation.
What Are the Potential Side Effects of RAD-140? Key Research Findings
The following adverse effects may occur with RAD-140 use. We have ranked each side effect by how prevalent it is among our patients, with one indicating the most commonly observed and five the least:
- Hepatotoxicity [25]
- Hypertension [26]
- Hypogonadism
- Gynecomastia and edema
- Alopecia and prostatic hyperplasia (prostatic enlargement)
In animal studies, RAD-140 has been shown to be less toxic than testosterone replacement therapy (TRT) when administered to rats [27]. However, there appears to be a different trend in certain humans, with RAD-140 demonstrating harsher side effects. Nicholas Downey, who holds a PhD in Molecular and Cellular Biology, states that clinical research indicates RAD-140 at 50 mg daily can cause liver complications [28].
Additionally, Dr. Downey remarks that RAD-140 exhibits a notable suppressive effect in some individuals. However, the extent of gonadal suppression remains uncertain due to the paucity of human studies.
Patricia LoRusso, a professor at Yale School of Medicine, was a lead author of the first-in-human Phase 1 study of RAD-140 in patients with metastatic breast cancer. Professor LoRusso states that RAD-140 demonstrated “acceptable safety, despite some patients experiencing raised liver enzyme levels, vomiting, dehydration, and decreased appetite.”
1. Hepatotoxicity
Flores et al. (2020) suggest that RAD-140 can cause hepatocellular-cholestatic liver injury in humans [29,30].
A 49-year-old male patient received continuous supplementation with RAD-140 for a duration of 4 weeks [31], followed by intermittent use thereafter.
During this period, the user concurrently administered RAD-140 alongside venlafaxine (Effexor), an antidepressant they had been prescribed and taking regularly for the previous 11 months.
The individual’s alcohol consumption was negligible. Therefore, the concomitant use of hepatotoxic antidepressants and SARMs may constitute a potentially deleterious combination [32].
The user depicted in the second RAD-140 before-and-after images also reported markedly elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicative of hepatic stress.
Dr. Thomas O’Connor, based on his decade of experience analyzing over 2,000 patients using SARMs, has compared their hepatotoxic effects to those associated with a 50 mg daily dose of Anavar (oxandrolone).
Dr. Ankit Batra also affirms that in clinical studies, the hepatic complications of RAD-140 can be similar to those of anabolic steroids. However, cases of hypertransaminasemia (elevated transaminases) typically normalize post-cycle [33].
The oral administration route of RAD-140 is hypothesized to be the primary contributor to hepatic stress.
RAD-140 needs to bypass first-pass metabolism in the liver upon entry into the bloodstream, a characteristic shared with C-17 alpha-alkylated anabolic steroids, which have been demonstrated in human studies to be hepatotoxic [34,35].
Therefore, if an individual has elevated liver enzymes and starts taking RAD-140, they are at a higher risk of liver injury. Other users with healthy livers may not experience any notable deterioration in hepatic health from RAD-140 cycles.
RAD-140 users can reduce the risk of liver injury by supplementing with 500 mg per day of tauroursodeoxycholic acid (TUDCA). TUDCA is a natural bile acid supplement that has demonstrated notable hepatoprotective effects in clinical research [36].
2. Hypertension
RAD-140 and other SARMs may exert a dose-dependent influence on lipid profiles, specifically cholesterol and triglyceride levels. Such alterations could potentially elevate the risk of:
- Atherosclerosis [37]
- Myocardial infarction
- Cerebrovascular accident
The second user, who documented a before-and-after transformation, reported a notable increase in blood pressure.
This effect is likely attributable to SARMs’ hepatic metabolism, which may stimulate hepatic lipase activity, leading to a reduction in high-density lipoprotein (HDL) cholesterol levels.
Our tests indicate that elevated HDL cholesterol is cardioprotective, with higher levels associated with a decreased accumulation of arterial plaque.
Another potential factor contributing to adverse alterations in blood lipid profiles is RAD-140’s inability to undergo aromatization.
Conversely, several anabolic steroids are metabolized into 17β-estradiol, which exerts a beneficial effect on lipid metabolism by elevating HDL levels.
Consequently, research indicates that inhibiting this aromatization process may be detrimental to cardiovascular health, as it diminishes estrogen’s protective influence on lipid profiles [38].
Therefore, RAD-140 users with high blood pressure before supplementation are likely to exacerbate it. However, other users with optimal blood pressure may not experience hypertension during cycles, especially if utilizing conservative doses.
Supplementation with vitamin K2 (menaquinone) at a dosage of 150 μg per day may mitigate excessive fluctuations in cholesterol and blood pressure. We have found that vitamin K2 can contribute to the reduction of blood pressure and the prevention of arterial stiffening by facilitating the regulation of calcium deposition in vascular tissues.
3. Hypogonadism
RAD-140’s potent binding affinity to the AR may lead to suppression of endogenous testosterone production and impairment of spermatogenesis, akin to the effects observed with anabolic steroid use.
The degree of endocrine suppression induced by SARMs remains to be fully characterized.
It is not uncommon for an individual’s total testosterone level, which may be approximately 600 ng/dL before initiating RAD-140, to decrease to around 300 ng/dL following an 8-week treatment cycle.
The second user’s before-and-after transformation was attained by administering 17 mg/day of RAD-140 for 12 weeks. However, they experienced a significant reduction in serum testosterone levels, decreasing from 750 to 193 ng/dL.
Therefore, male hypogonadism may occur following RAD-140 administration due to disruption of the hypothalamic-pituitary-testicular axis (HPTA), potentially impairing long-term fertility in users.
All SARMs are associated with suppressive effects on endogenous testosterone production. However, the impact of RAD-140 appears to be more pronounced than that of other SARMs, likely attributable to its higher potency.
Men with low testosterone before supplementation may be at risk of becoming hypogonadal and/or infertile by taking RAD-140. Other men’s testosterone levels may remain within the normal range after RAD-140 cycles, especially if they were high pre-cycle.
Some of our patients employ human chorionic gonadotropin (hCG) therapy following a RAD-140 cycle to address hypogonadism. Clinicians typically prescribe a dosage of 2,000 IU administered 3 times per week, aiming to facilitate the recovery of the HPTA and restore normal testosterone levels in affected individuals. However, doses can vary based on the level of testosterone suppression and the person’s weight.
4. Gynecomastia and Fluid Retention
Although RAD-140 lacks aromatization capability, it may still contribute to elevated estrogen levels through alternative mechanisms.
Upon administration, SARMs compete with endogenous testosterone for binding to ARs. Due to their higher binding affinity, SARMs preferentially occupy these receptors, causing a reduction in free testosterone.
Consequently, the decreased availability of endogenous testosterone can lead to increased conversion of the remaining free testosterone into estrogen and DHT, thereby elevating the levels of these hormones.
Indicators of Elevated Estrogen Levels During RAD-140 Usage
Elevated levels of estrogen can cause:
- Fluid retention
- Abdominal bloating
- Gynecomastia
Michael Moeller holds a Bachelor of Science in pre-medical sciences from Southern Illinois University Carbondale. Moeller has reported overseeing male patients who experienced milk secretion as a side effect of SARM use.
Therefore, initiating a RAD-140 cycle with a mild aromatase inhibitor (AI) may provide a protective effect against estrogen-related side effects, such as gynecomastia and milk secretion [39].
Which AIs Can Regulate Estrogen?
Diindolylmethane (DIM) is a naturally occurring phytochemical found in cruciferous vegetables that possesses AI properties, enabling its use in mitigating estrogen-related side effects. Based on our clinical experience, supplementation with 200 mg of DIM daily during RAD-140 cycles can effectively manage elevated estrogen levels in some patients, contributing to improved hormonal regulation during such regimens.
Potent AIs are generally considered excessively harsh for most SARM cycles, including the following:
- Letrozole (Femara)
- Exemestane (Aromasin)
- Anastrozole (Arimidex)
The aforementioned AIs may induce hormonal imbalances, resulting in estrogen deficiency. These AIs are more commonly employed during anabolic steroid cycles, where estrogen levels can be significantly elevated.
Utilizing AIs as post-cycle therapy (PCT) agents, without a medical prescription, remains illegal in the US.
5. Alopecia and Prostatic Hyperplasia (Prostatic Enlargement)
Animal studies suggest that RAD-140’s tissue selectivity may confer therapeutic benefits for individuals with benign prostatic hyperplasia (prostatic enlargement), potentially inducing prostate atrophy [40]. In rat models, RAD-140 exhibited minimal androgenic activity and necessitated a dose approximately 60 times higher than testosterone to induce comparable prostatic hypertrophy.
However, we have had some patients cycle RAD-140 and exhibit signs of androgenization, including the development of androgen-dependent secondary sexual characteristics and episodes of alopecia.
Such incidences may be attributed to the endogenous conversion of testosterone to DHT. Clinical research suggests that elevated DHT levels may contribute to increased inflammation and follicular miniaturization of the scalp [41].
Saw palmetto (Serenoa repens) is a botanical supplement that functions as a 5-alpha-reductase inhibitor (5-ARI), an enzyme responsible for converting testosterone to DHT. By inhibiting this enzymatic activity, saw palmetto may serve as a potential intervention to mitigate androgen-related side effects. Many of our patients have benefited from a 320 mg daily dose of saw palmetto for preventing reduced hair density and hairline recession during RAD-140 cycles.
Can RAD-140 Accelerate Androgenetic Alopecia?
Based on our observations, short-term use of RAD-140 can cause mild alopecia. However, this side effect is often reversible for most users following drug cessation.
This transient effect is likely attributable to hormonal fluctuations and regulation during the post-cycle period. However, prolonged use and sustained elevation of DHT levels may increase the risk of developing androgenetic alopecia.
Additionally, increased sebum production has been reported by some users, causing acne vulgaris in a few sensitive individuals.
Supplementation with zinc picolinate has been shown to mitigate acne flare-ups in some men and women, owing to its:
- Anti-inflammatory properties
- Ability to regulate sebum secretion
- Inhibitory effects on 5-AR activity
Our medical doctors have observed that 15 mg of zinc picolinate per day is effective in reducing the incidence of nodulocystic acne in several patients undergoing RAD-140 cycles.
Theoretically, the tissue selectivity of RAD-140 should mitigate the occurrence of androgenic side effects, as suggested by animal studies [42].
However, its indirect influence on the conversion of endogenous testosterone to DHT may pose potential concerns for human users.
RAD-140 PCT

RAD-140 has the potential to suppress endogenous testosterone production by decreasing levels of:
- Follicle-stimulating hormone (FSH)
- Luteinizing hormone (LH)
This suppression is attributed to RAD-140’s high affinity for ARs, which can influence the HPTA. Consequently, some users observe significant declines in their testosterone levels following the cycle, prompting the implementation of PCT.
Given RAD-140’s reported half-life of approximately 60 hours, PCT may be initiated approximately 12 days after discontinuation of the SARM.
Complete elimination of RAD-140 can be estimated with the following calculation: 5.5 multiplied by its half-life (60 hours). However, we observe that our patients’ volume of distribution can impact clearance time. Individuals with greater muscle and fat mass demonstrate an extended drug retention duration due to a larger volume of distribution.
Clomid (clomiphene citrate) or Nolvadex (tamoxifen citrate) is commonly taken during PCT, with our tests showing that Nolvadex is often the stronger medication for restoring endogenous testosterone levels. For the majority of our patients, Clomid is sufficient for PCT after a RAD-140-only cycle. However, we find that Nolvadex is typically more optimal for patients who have stacked RAD-140 with other SARMs.
Clomid exerts its effects by acting as an estrogen receptor (ER) antagonist in the hypothalamus, the brain’s central regulatory region.
This activation leads to an increased secretion of gonadotropins from the anterior pituitary gland, thereby promoting endogenous testosterone production.
In essence, Clomid simulates a state of reduced estrogen activity in the brain, resulting in enhanced signaling to the testes to elevate testosterone synthesis.
Regarding PCT with RAD-140, below are examples of typical dosage regimens and durations.
| Duration | Nolvadex Dosage |
|---|---|
| Day 1–30 | 20 mg/day |
| Duration | Clomid Dosage |
|---|---|
| Day 1–30 | 25 mg/day |
The above protocols are common examples. However, doses should be tailored to the individual by a healthcare professional for optimal results. Doses should be based on the person’s weight and the level of suppression. Additionally, if they experience any adverse effects from Clomid or Nolvadex, doses should be revised and potentially reduced.
Legal RAD-140 Alternative
TESTOL 140 is our recommended RAD-140 alternative, mimicking the anabolic effects of RAD-140 but without any testosterone suppression or hepatotoxicity.
It is FDA-approved and thus legal to purchase for human consumption.
TESTOL 140 is best utilized during muscle-gain phases for maximum hypertrophy and strength. It can also inhibit adipose tissue accumulation when eating in a calorie surplus.
What is the Half-Life of RAD-140?
Pharmacokinetic studies have determined that RAD-140’s half-life is approximately 60 hours [43].
RAD-140 vs. LGD-4033: What Is the Difference?

Best for Potency
LGD-4033 (Ligandrol) is generally considered to be more potent per milligram than RAD-140.
According to various bodybuilders under our care, effective results can be achieved with daily dosages of LGD-4033 ranging from 2 to 10 mg. In comparison, RAD-140 is typically administered at dosages between 10 and 20 mg per day.
These dosing differences reflect the relative potency and pharmacodynamic profiles of the respective compounds.
Best for Pumps, Fat Loss, and Muscle Tone
RAD-140 may be regarded as the superior SARM in terms of promoting:
- Enhanced muscle pumps
- Reductions in subcutaneous fat
Some of our patients state that LGD-4033 can cause increased fluid retention; therefore, the SARM may be less suitable for individuals aiming for:
- A lean physique
- Maximum muscle definition
Fat loss associated with RAD-140 may be indirect, attributable to it increasing satiation—the sensation of fullness that terminates hunger.
In a first-in-human, phase 1 study of RAD-140, 27% of patients with metastatic breast cancer reported decreased appetite [44]. Based on our patient feedback, the appetite-suppressant effects of RAD-140 appear to be superior to those of LGD-4033 in most users.
Best for Muscle Hypertrophy and Strength
In terms of muscle hypertrophy and strength, LGD-4033 and RAD-140 demonstrate comparable potency.
RAD-140 exhibits a more pronounced muscle-hardening effect, potentially attributable to a lesser increase in estrogen levels, which consequently reduces fluid retention.
Research has indicated that RAD-140 suppresses the expression of the ER-1 gene [45], a mechanism believed to contribute to its reduction in extracellular water volume (fluid outside the cells).
Best for Endurance and Energy Levels
RAD-140 is likely to elicit more pronounced improvements in muscular endurance. Consequently, RAD-140 may be particularly advantageous for individuals engaging in high-repetition training or cardiovascular exercise.
Our patients frequently report higher energy levels when using RAD-140 compared to LGD-4033. However, some also state that LGD-4033 can have a more positive impact on libido during cycles.
The current market prices for RAD-140 and LGD-4033 can be viewed below:
| RAD-140 Price | LGD-4033 Price |
|---|---|
| $64.99 | $59.99 |
Prices were obtained from Sports Technology Labs.
What Are RAD-140’s Stacking Options?

From an ethical and legal standpoint, RAD-140 should not be taken by humans, whether alone or stacked with other SARMs.
Nonetheless, some bodybuilders combine RAD-140 with other SARMs to synergistically enhance outcomes related to:
- Muscular strength
- Muscle hypertrophy
- Reduction in fat
According to Leciejewska et al. (2023), the concurrent utilization of multiple SARMs may further intensify adverse effects observed in vitro [46].
We have observed that some novice SARM users commence with a RAD-140-only cycle to familiarize themselves with the pharmacological effects of the compound. As users gain experience, it is common to incorporate more potent stacks.
For Lean Mass and Strength
Combining RAD-140 with LGD-4033 is a protocol used by some weightlifters to increase lean mass and strength during muscle-gain phases [47].
Regarding dosage regimens, a typical RAD-140 and LGD-4033 stack that users administer is as follows:
| Week | RAD-140 Dosage | LGD-4033 Dosage |
|---|---|---|
| 1–8 | 10 mg/day | 6 mg/day |
However, considering the preliminary evidence suggesting potential toxic effects of RAD-140 in human studies [48], it is advisable to exercise caution if combining it with additional SARMs until further research elucidates its safety profile.
Frequently Asked Questions

Are There Specific Health Conditions That Would Contraindicate the Use of RAD-140?
Yes, individuals with pre-existing hypertension may experience further cardiac deterioration with RAD-140 use due to its negative effects on lipid profiles in certain users.
For example, one of our patients with a pre-existing history of hypertension subsequently developed atherosclerosis following RAD-140 supplementation.
This condition was characterized by the accumulation of atheromatous plaque within the arterial walls following an 8-week cycle of RAD-140 in combination with LGD-4033.
Furthermore, another patient of ours developed peliosis hepatis, a rare hepatic condition characterized by the formation of blood-filled spaces within the liver parenchyma.
This diagnosis was the result of a 12-week course of RAD-140, administered at 20 mg daily in conjunction with monoamine oxidase inhibitors (MAOIs).
These cases underscore the potential increased risk for individuals utilizing SARMs with pre-existing health conditions or those concurrently using specific medications.
Therefore, comprehensive medical evaluation is critical before the initiation of RAD-140 treatment.
Are RAD-140 Capsules Effective?
Yes, RAD-140 capsules can be effective. However, as with liquid and powder versions, high purity levels and accurate dosing are crucial. We recommend SwissChems for researchers seeking to buy RAD-140 capsules, as the company guarantees over 99% purity.
Can Research Subjects Consume Alcohol While Taking RAD-140?
Given that RAD-140 has been associated with hepatotoxic effects [25], concurrent consumption of alcohol during a RAD-140 cycle may exacerbate hepatic injury and increase the risk of liver damage.
What Is the Optimal Diet When Supplementing With RAD-140?
In our experience, most weightlifters typically employ RAD-140 for mass-gain phases. In this context, a surplus of approximately 500 calories above maintenance levels is recommended to promote anabolic processes and muscle hypertrophy [49].
Conversely, when RAD-140 is used for fat-loss phases, many of our patients have found that a caloric deficit of 500 calories enhances fat loss while preserving lean muscle mass [50].
Are There Any Supplements That Can Help Reduce the Toxicity Associated With RAD-140?

Yes, TUDCA has been shown to reduce AST and ALT serum levels [36], potentially mitigating hepatotoxicity during a RAD-140 cycle.
Additionally, 3 g of fish oil per day, containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may aid in blood pressure regulation. Clinical evidence suggests that fish oil supplementation can decrease cardiovascular risk; however, the magnitude of these benefits appears to be dose-dependent [51].
Can RAD-140 Cause Abdominal Bloating?
Some of our patients utilizing RAD-140 have reported abdominal bloating as a side effect. Evidence suggests that reducing sodium intake may effectively alleviate this symptom, likely through the reduction of plasma osmolality—the concentration of solutes in the blood.
By implementing dietary modifications to promote diuresis (increased urine production), certain bodybuilders under our supervision have achieved up to 3 kg (6.61 lb) of water loss during RAD-140 cycles.
What Is Dr. O’Connor’s Experience With RAD-140?

Dr. Thomas O’Connor believes SARMs, such as RAD-140, are “potentially more dangerous than anabolic steroids.” This opinion is based on the regular analysis of laboratory tests from over 2,000 patients.
Nevertheless, further clinical research on RAD-140 is required to fully understand its effects, as certain users may observe positive changes in body composition without any discernible complications.
Can RAD-140 Cause a Failed Drug Test?
RAD-140 and other SARMs are prohibited substances under the regulations of WADA and the United States Anti-Doping Agency (USADA).
Due to the sensitivity of contemporary analytical techniques, such as liquid chromatography–mass spectrometry (LC–MS), even trace amounts of these compounds can be detected in biological samples.
David Drouin, a Canadian cyclist, was the first individual to test positive for RAD-140 in a sporting context. Following a random at-home test, Drouin received a 4-year suspension from competition sanctioned by the following organizations:
- Cycling Canada
- The Union Cycliste Internationale (UCI)
- The International Olympic Committee (IOC)
Another prominent case involves Ricky Garard, who tested positive for RAD-140 after achieving third place at the 2017 Reebok CrossFit Games.
Athletes are strongly advised to consult their respective governing bodies and regulatory organizations to ascertain whether the use of RAD-140 is permitted within their sport, as violations can lead to significant sanctions.
RAD-140 Pros and Cons

Pros:
- May increase muscle hypertrophy
- May significantly enhance muscular strength
- May promote reductions in body fat
Cons:
- Smaller increases in fat-free mass (FFM) compared to anabolic steroids
- May increase cholesterol levels
- May decrease endogenous testosterone production
- Potential hepatotoxic effects
Summary
RAD-140 displays anabolic traits that may be beneficial to those seeking improvements in muscle hypertrophy and strength.
Some of our patients have described RAD-140 as the best SARM for intermediate users wanting to increase muscle mass. However, there appear to be anabolic steroid-like risks associated with RAD-140, particularly concerning hepatotoxicity and cardiovascular stress.
Such deteriorations in health are evident in several human trials and correlate with Dr. Thomas O’Connor’s 10 years of experience treating males and females on RAD-140.
RAD-140 may be a less suitable treatment for cachexia than the following anabolic steroids, due to the occurrence of toxic effects in some users and only modest increases in lean mass:
- Testosterone
- Anavar
- Deca-Durabolin
Testosterone is also known as:
- Depo-Testosterone
- Testoviron
- AndroGel
- TestoGel
- Andriol
- Aveed
Anavar is also known as:
- Oxandrin
- Lonovar
- Protivar
- Vasorome
Deca-Durabolin is also known as:
- 19-Nortestosterone 17β-decanoate
- Rolon
If individuals have been exposed to RAD-140, it is essential to consult a medical professional for proper health monitoring. Since each person may respond differently to RAD-140 due to their unique genetic makeup and lifestyle factors, personalized medical guidance is crucial to ensure optimal health and safety.
Relevant Research
- Preclinical assessment of the SARM RAD-140 to increase muscle mass and bone mineral density
- RAD-140 drug-induced liver injury
- SARM RAD-140 is neuroprotective in cultured neurons and kainate-lesioned male rats
- Treatment with RAD-140 is linked to better cardiac function, with male-specific effects that are graded by interleukin-6
- RAD-140 negatively impacts skeletal muscle adaptation, frailty status, and mortality risk in female mice
- Idiosyncratic drug-induced liver injury related to use of novel SARM RAD-140: a case report
- Human in vivo metabolism and elimination behavior of micro-dosed SARM RAD-140 for doping control purposes
Co Authors :
References
(1) https://pmc.ncbi.nlm.nih.gov/articles/PMC2907129/
(2) https://pubmed.ncbi.nlm.nih.gov/24428527/
(3) https://pmc.ncbi.nlm.nih.gov/articles/PMC10403398/
(4) https://pubmed.ncbi.nlm.nih.gov/24189892/
(5) https://pubmed.ncbi.nlm.nih.gov/39755947
(6) https://pmc.ncbi.nlm.nih.gov/articles/PMC10392554/
(7) https://www.sciencedirect.com/science/article/pii/S266608492400216X
(8) https://pmc.ncbi.nlm.nih.gov/articles/PMC3959610/
(9) https://academic.oup.com/jcem/article-abstract/83/2/320/2865101
(10) https://pmc.ncbi.nlm.nih.gov/articles/PMC9331610/
(11) https://academic.oup.com/jcem/article-abstract/81/12/4249/2650464
(12) https://pubmed.ncbi.nlm.nih.gov/10889795/
(13) https://pmc.ncbi.nlm.nih.gov/articles/PMC12274021/
(14) https://pubmed.ncbi.nlm.nih.gov/10589853/
(15) https://pubmed.ncbi.nlm.nih.gov/20020375/
(16) https://www.ncbi.nlm.nih.gov/books/NBK548931/
(17) https://ec.bioscientifica.com/view/journals/ec/9/4/EC-19-0557.xml
(18) https://onlinelibrary.wiley.com/doi/10.1111/ijd.17567
(19) https://www.sciencedirect.com/science/article/abs/pii/S0960076018306885
(20) https://www.ochsnerjournal.org/content/22/4/361
(21) https://www.sciencedirect.com/science/article/abs/pii/S0305417918302870
(22) https://www.sciencedirect.com/science/article/abs/pii/S0003267004013650
(23) https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4018048/
(24) https://pubmed.ncbi.nlm.nih.gov/23650030/
(26) https://pmc.ncbi.nlm.nih.gov/articles/PMC10420890/
(28) https://www.sciencedirect.com/science/article/abs/pii/S1526820921002408
(30) https://pubmed.ncbi.nlm.nih.gov/38444893/
(31) https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7049679/
(32) https://pmc.ncbi.nlm.nih.gov/articles/PMC6061298/
(33) https://pmc.ncbi.nlm.nih.gov/articles/PMC10024817/
(34) https://bmjopengastro.bmj.com/content/7/1/e000549
(35) https://pubmed.ncbi.nlm.nih.gov/4423214/
(36) https://www.sciencedirect.com/science/article/abs/pii/S0011393X05806599
(37) https://pubmed.ncbi.nlm.nih.gov/37571268/
(38) https://academic.oup.com/cardiovascres/article-abstract/69/4/777/344756
(39) https://pmc.ncbi.nlm.nih.gov/articles/PMC3042921/
(40) https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC3959610/
(41) https://pmc.ncbi.nlm.nih.gov/articles/PMC4174066/
(42) https://www.sciencedirect.com/science/article/pii/S1526590022001249
(43) https://cancerres.aacrjournals.org/content/80/4_Supplement/P5-11-01
(44) https://pubmed.ncbi.nlm.nih.gov/34565686/
(45) https://pubmed.ncbi.nlm.nih.gov/28974548/
(46) https://www.sciencedirect.com/science/article/pii/S0303720723001880/
(47) https://pmc.ncbi.nlm.nih.gov/articles/PMC4111291/
(48) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535764/
(49) https://www.sciencedirect.com/science/article/pii/S0261561424003467
(50) https://pubmed.ncbi.nlm.nih.gov/18549992/
(51) https://www.ahajournals.org/doi/full/10.1161/JAHA.121.025071
(52) https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.13824
(53) https://pubmed.ncbi.nlm.nih.gov/34565686/
(55) https://pubmed.ncbi.nlm.nih.gov/33062783/
(56) https://pubmed.ncbi.nlm.nih.gov/32140660/

